Hepatitis C treatment for people awaiting trial in jail
Treatments studied
Part of Digestive system, Infections clinical trials.
This study offers a once-daily pill (Epclusa) to treat hepatitis C for people in jail who have never taken HCV medicine before. The goal is to see if starting treatment while incarcerated and continuing after release can cure the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in jail at RIDOC and are at least 18 years old.
- You are awaiting trial (not yet sentenced) and speak English.
- You have active hepatitis C (detected in a blood test within the last 3 months) and have never been treated for it before.
- You have injected drugs at least once and do not have cirrhosis.
- You are willing to take a medication called Epclusa (sofosbuvir/velpatasvir), continue it after release, and be contacted after jail.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether people who come to the emergency department can get tested for hepatitis C and start treatment right away, all in one visit. It aims to make treatment easier and faster for those who test positive.
This study tests hepatitis C virus (HCV) treatment using medications called sofosbuvir and velpatasvir, with the goal of curing the infection. If you've been treated before and the virus came back, you may be eligible for retreatment with additional medication.
This study tests a team-based approach — a pharmacist, doctor, and patient navigator working together — to help people living in permanent supportive housing get hepatitis C care. If you have hepatitis C and live in DESC housing, the study will check how well this team helps you through treatment over 2 years.
This trial offers hepatitis C treatment to people in Idaho county jails who have been there for at least 10 days. It uses a simple, proven treatment plan for adults who are newly diagnosed and do not have liver scarring.
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.
Hear when a new HEPATITIS C (HCV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.